Abstract A novel single base-pair polymorphism, G/A at ntd 955, was identified within the coding region of the glutamate dehydrogenase gene (GLUD1). This polymorphism should prove useful for the study of human disorders with altered ammonia and/or blood glucose levels.
alleles showed similar gene frequency. Since this enzyme is a key enzyme connecting glutamate and energy metabolism, we believe this polymorphism should prove useful not only for the study of hyperinsulinism-hyperammonemia syndrome but also for the study of other disorders with altered ammonia and/or blood glucose levels.
Polymerase chain reaction (PCR) conditions
Since the mutation does not alter pre-existing restriction sites of the gene, we designed a mismatched primer pair so that in the presence of the G allele the PCR products would contain an RsaI restriction site.
Forward primer: 5Ј-CAGGGATTTGGTAATGTGGGCGT-3Ј Reverse primer: 5Ј-CCATCAGACTCACCAACAGC-3Ј PCR was performed in 5-µl reaction mixtures containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 0.01%(w/v) gelatin, 200 mM of each dNTP, 5 pmol of each mismatch primer, and 0.125 units of AmpliTaq Gold DNA polymerase (Perkin-Elmer, NJ, USA). The cycling parameters consisted of initial activation at 94°C for 10 min followed by 30 cycles of denaturation at 94°C for 1 min, and annealing and extension at 53°C for 20 s. The PCR products were digested with RsaI and electrophoresed on a 10% denaturing polyacrylamide gel.
Polymorphism and allele frequency Figure 1 shows a representative result of the analysis. The allele frequencies of the polymorphisms among 33 Japanese individuals are shown in Table 1 .
Introduction
Glutamate dehydrogenase (EC1.4.1.3) is a ubiquitously distributed mitochondrial matrix enzyme which catalyzes the reversible conversion of glutamate to α-ketoglutarate. The gene (GLUD1) spans about 45 kb on chromosome 10q21.1-q24.3 and is split into 13 exons (Michaelidis et al. 1993) . Unlike brain-specific glutamate dehydrogenase, deficiency of which leads to a form of neurodegenerative disease (Plaitakis et al. 1988) , the role of GLUD1 in human disease remained unknown until recently, when Stanley et al. (1998) identified activating mutations of GLUD1 in patients with hyperinsulinism-hyperammonemia syndrome. Most of the mutations lie in the guanosine triphosphate (GTP) binding site of the gene, which is essential for the GTP-mediated allosteric inhibition of the enzyme. However, there are other mutations outside the GTP binding site, suggesting that different mutations affect the enzyme activity differently.
In a previous attempt to determine mutations in patients with hyperinsulinism-hyperammonemia syndrome, we identified a novel single base-pair polymorphism, G/A at ntd 955, within the coding region of GLUD1 (Nakatani et al. 1988) . Among the Japanese subjects studied, these two 
